BR112023017657A2 - Formas sólidas de saflufenacil sódico e saflufenacil potássico, processo de preparação e uso das mesmas - Google Patents

Formas sólidas de saflufenacil sódico e saflufenacil potássico, processo de preparação e uso das mesmas

Info

Publication number
BR112023017657A2
BR112023017657A2 BR112023017657A BR112023017657A BR112023017657A2 BR 112023017657 A2 BR112023017657 A2 BR 112023017657A2 BR 112023017657 A BR112023017657 A BR 112023017657A BR 112023017657 A BR112023017657 A BR 112023017657A BR 112023017657 A2 BR112023017657 A2 BR 112023017657A2
Authority
BR
Brazil
Prior art keywords
saflufenacil
potassium
sodium
solid forms
preparation process
Prior art date
Application number
BR112023017657A
Other languages
English (en)
Inventor
Kumar Jha Ashok
Daniel Meliker
Lior Ziserman
Michael Grabarnick
Vasantrao GALGE Revanappa
Sergio Nahmoud
Original Assignee
Adama Agan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adama Agan Ltd filed Critical Adama Agan Ltd
Publication of BR112023017657A2 publication Critical patent/BR112023017657A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P13/00Herbicides; Algicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

formas sólidas de saflufenacil sódico e saflufenacil potássico, processo de preparação e uso das mesmas. a presente invenção se refere a formas sólidas inovadoras de saflufenacil sódico ou saflufenacil potássico. a presente invenção se refere adicionalmente a um processo para produzir as ditas formas sólidas inovadoras de saflufenacil sódico ou saflufenacil potássico. além disso, a presente invenção se refere ao uso das formas sólidas inovadoras de saflufenacil sódico ou saflufenacil potássico.
BR112023017657A 2021-03-04 2022-03-04 Formas sólidas de saflufenacil sódico e saflufenacil potássico, processo de preparação e uso das mesmas BR112023017657A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202131009160 2021-03-04
PCT/IL2022/050246 WO2022185322A1 (en) 2021-03-04 2022-03-04 Solid forms of saflufenacil-sodium and saflufenacil-potassium, process of preparation and use thereof

Publications (1)

Publication Number Publication Date
BR112023017657A2 true BR112023017657A2 (pt) 2023-09-26

Family

ID=80930120

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023017657A BR112023017657A2 (pt) 2021-03-04 2022-03-04 Formas sólidas de saflufenacil sódico e saflufenacil potássico, processo de preparação e uso das mesmas

Country Status (8)

Country Link
US (1) US20240174620A1 (pt)
CN (1) CN116917274A (pt)
AU (1) AU2022230103A1 (pt)
BR (1) BR112023017657A2 (pt)
CA (1) CA3210637A1 (pt)
IL (1) IL305643A (pt)
MX (1) MX2023010176A (pt)
WO (1) WO2022185322A1 (pt)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1226127T1 (sl) 2000-05-04 2009-10-31 Basf Se Substituirani fenilsulfamoil karboksamidi
DK1506169T3 (da) 2002-05-16 2010-04-19 Basf Se Fremgangsmåde til fremstilling af sulfonsyrediamider
US7737275B2 (en) 2003-12-03 2010-06-15 Basf Aktiengesellschaft Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils
CA2574406C (en) 2004-07-22 2013-02-19 Basf Aktiengesellschaft Method for the production of 3-phenyl(thio)uracils and dithiouracils
FR2883150B1 (fr) 2005-03-15 2007-04-20 Seb Sa Surface de cuisson facile a nettoyer et article electromenager comportant une telle surface
BRPI0609798B1 (pt) * 2005-05-24 2015-01-27 Basf Se Processo para a preparação de compostos
MX2009003431A (es) 2006-10-13 2009-04-14 Basf Se Hidratos de 2-cloro-5-[3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorom etil)-1-(2h)-pirimidinil]-4-fluor-n-[[metil(1-metiletil)amino]sul fonil]benzamida.
WO2008043835A2 (de) 2006-10-13 2008-04-17 Basf Se Kristalline form von 2-chlor-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluormethyl)-1-(2h)-pyrimidinyl]-4-fluor-n-[[methyl-(1-methylethyl)amino]sulfonyl]benzamid
WO2011023759A2 (en) * 2009-08-27 2011-03-03 Basf Se Aqueous suspension concentrate formulations containing saflufenacil
AU2018373514B2 (en) * 2017-11-27 2023-06-01 Basf Se Crystalline forms of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3- methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate
AU2020287239A1 (en) * 2019-06-07 2022-01-06 BASF Agro B.V. Microparticle compositions comprising saflufenacil

Also Published As

Publication number Publication date
CN116917274A (zh) 2023-10-20
WO2022185322A1 (en) 2022-09-09
MX2023010176A (es) 2023-09-07
US20240174620A1 (en) 2024-05-30
IL305643A (en) 2023-11-01
AU2022230103A1 (en) 2023-10-05
CA3210637A1 (en) 2022-09-09

Similar Documents

Publication Publication Date Title
CL2018000039A1 (es) Derivados de oxopiridina sustituidos
CL2018000829A1 (es) Anticuerpos anti-cd19 humano con alta afinidad
BR112014030020A2 (pt) aparelho para montagem de seções de pá
CR20200554A (es) Derivados sustituidos de la carboxamida dihidropirazolo pirazina
BR112018072246A2 (pt) síntese de indazóis
CO2020009402A2 (es) Proteínas de fusión fc il-22 y métodos de uso
BR112019003987A2 (pt) formas sólidas de mesilato de cenicriviroc e processos de produção das formas sólidas de mesilato de cenicriviroc
BR112017028322A2 (pt) compostos, processo para a produção de compostos i, para a produção de compostos ii dos compostos iii e para a produção de compostos iii, compostos intermediários v e utilização dos compostos i
CO2022002001A2 (es) Usos terapéuticos de anticuerpos anti-variable delta 1 de tcr
BR112018013985A2 (pt) glicosídeos de esteviol altamente solúveis
BR112017009545B8 (pt) Composição antibacteriana farmacêutica ou veterinária e método in vitro para a preparação de uma composição farmacêutica ou veterinária
BR112018070448A2 (pt) derivados de aminotiazol úteis como agentes antivirais
CL2021001037A1 (es) Formulación de anticuerpos
BR112019020338A8 (pt) Composição para produção de tagatose, e, método de produção de tagatose
EA202190810A1 (ru) Способы и наборы для получения цельной крови с инактивированным патогеном
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
CO2023013500A2 (es) Anticuerpos anti-cd19 y estructuras car-t
BR112023017657A2 (pt) Formas sólidas de saflufenacil sódico e saflufenacil potássico, processo de preparação e uso das mesmas
BR112021000279A8 (pt) formulações de redução de tumor e métodos de uso das mesmas
BR112022009244A2 (pt) Complexo, composição, kit, uso de um complexo, substância antibiótica derivatizada, método para produzir uma substância antibiótica estabilizada e usos de um reagente de derivatização nucleofílica e de um antibiótico derivatizado
CO2021008763A2 (es) Enzima de desfosforilación del nuevo ácido psicosa-6-fosfórico, composición para producir psicosa que comprende la misma y método para preparar psicosa usando la misma
BR112022012221A2 (pt) Composições de enterovírus purificadas e métodos de purificação com cromatografia de afinidade por glutationa
BR112021022429A2 (pt) Produção de conjugados
BR112019002132A2 (pt) composições anti-retrovirais
BR112023012460A2 (pt) Conjunto in vitro de capsídeos de anellovirus que envolvem rna